FIVCX | VMVAX | FIVCX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 2 years | 13 years | - |
Gain YTD | 2.631 | 12.962 | 20% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | N/A | 32.8B | - |
Annual Yield % from dividends | 0.29 | 2.14 | 14% |
Returns for 1 year | 3.36 | 13.66 | 25% |
Returns for 3 years | N/A | 11.75 | - |
Returns for 5 years | N/A | 38.87 | - |
Returns for 10 years | 157.54 | 83.91 | 188% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYVYX | 577.64 | 11.23 | +1.98% |
Rydex NASDAQ-100® 2x Strategy H | |||
DSMLX | 59.41 | 0.60 | +1.02% |
Touchstone Large Company Growth Instl | |||
IPMIX | 21.39 | 0.06 | +0.28% |
Voya Index Plus MidCap Port I | |||
BGSIX | 74.15 | N/A | N/A |
BlackRock Technology Opportunities Instl | |||
GEMJX | 12.01 | N/A | N/A |
Goldman Sachs Emerging Mkt Eq ex. ChnIns |